Table 4: Novel therapeutic modalities for SLE  
Newer immunosuppressive agents
 

Mycophenolate mofetil
Tacrolimus
Leflumomide

Hormones
  Dehydroepiandrosterone
B cell depletion
  Fludarabine, rituximab, epratuzumab, belimumab
B cell tolerogen
  LJP394-Riquent
Blockade of the co-stimulatory pathways
  Abatacept
Neutralization of cytokines
  IL-10, TNF, IL-6
Anti-complement
  Anti-C5b (eculizumab)
Immunoablative cyclophosphamide + stem cell rescue